BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32425892)

  • 1. Tolcapone Potently Inhibits Seminal Amyloid Fibrils Formation and Blocks Entry of Ebola Pseudoviruses.
    Qiu M; Li Z; Chen Y; Guo J; Xu W; Qi T; Qiu Y; Pang J; Li L; Liu S; Tan S
    Front Microbiol; 2020; 11():504. PubMed ID: 32425892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemically Modified Human Serum Albumin Potently Blocks Entry of Ebola Pseudoviruses and Viruslike Particles.
    Li H; Yu F; Xia S; Yu Y; Wang Q; Lv M; Wang Y; Jiang S; Lu L
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity.
    Ren R; Yin S; Lai B; Ma L; Wen J; Zhang X; Lai F; Liu S; Li L
    Retrovirology; 2018 Jul; 15(1):49. PubMed ID: 30012153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of Ebola virus infection by seminal amyloid fibrils.
    Bart SM; Cohen C; Dye JM; Shorter J; Bates P
    Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7410-7415. PubMed ID: 29941593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-parasitic drug suramin potently inhibits formation of seminal amyloid fibrils and their interaction with HIV-1.
    Tan S; Li JQ; Cheng H; Li Z; Lan Y; Zhang TT; Yang ZC; Li W; Qi T; Qiu YR; Chen Z; Li L; Liu SW
    J Biol Chem; 2019 Sep; 294(37):13740-13754. PubMed ID: 31346035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection.
    Xun T; Li W; Chen J; Yu F; Xu W; Wang Q; Yu R; Li X; Zhou X; Lu L; Jiang S; Li L; Tan S; Liu S
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5123-34. PubMed ID: 26055369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADS-J1 disaggregates semen-derived amyloid fibrils.
    Li J; Yang Z; Liu H; Qiu M; Zhang T; Li W; Li Z; Qi T; Qiu Y; Li L; Zhou X; Liu S; Tan S
    Biochem J; 2019 Mar; 476(6):1021-1035. PubMed ID: 30877194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Seminal Amyloids as Targets for Development of Synthetic Inhibitors of HIV Transmission.
    Sheik DA; Dewhurst S; Yang J
    Acc Chem Res; 2017 Sep; 50(9):2159-2166. PubMed ID: 28809479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Hydroxyphthalic Anhydride- Modified Rabbit Anti-PAP IgG as a Potential Bifunctional HIV-1 Entry Inhibitor.
    Zhang X; Chen J; Yu F; Wang C; Ren R; Wang Q; Tan S; Jiang S; Liu S; Li L
    Front Microbiol; 2018; 9():1330. PubMed ID: 29971062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEVI, the semen enhancer of HIV infection along with fragments from its central region, form amyloid fibrils that are toxic to neuronal cells.
    Elias AK; Scanlon D; Musgrave IF; Carver JA
    Biochim Biophys Acta; 2014 Sep; 1844(9):1591-8. PubMed ID: 24948476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 12. [Semen-derived enhancer of viral infection--a key factor in sexual transmission of HIV].
    Duan JM; Qiu JY; Tan SY; Liu SW; Li L
    Bing Du Xue Bao; 2012 Jan; 28(1):84-8. PubMed ID: 22416356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection.
    Zhang X; Ao Z; Bello A; Ran X; Liu S; Wigle J; Kobinger G; Yao X
    Antiviral Res; 2016 Mar; 127():20-31. PubMed ID: 26778707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of herpes simplex virus (HSV) infection by seminal plasma and semen amyloids implicates a new target for the prevention of HSV infection.
    Torres L; Ortiz T; Tang Q
    Viruses; 2015 Apr; 7(4):2057-73. PubMed ID: 25903833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ADS-J1 antagonizes semen-derived enhancer of virus infection-mediated enhancement of transmitted founder HIV-1 and its matched chronic control strain infection].
    Liu HM; Ma NN; Luo C; Yuan SY; Liu FL; Yao XG; Zhou CQ; Zou M
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Feb; 38(2):211-216. PubMed ID: 29502062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lactic acid inhibits the formation of semen-derived amyloid fibrils].
    Li JQ; Song YL; Xun TR; Tan SY; Liu SW
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jul; 37(7):907-913. PubMed ID: 28736366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein.
    Favier AL; Gout E; Reynard O; Ferraris O; Kleman JP; Volchkov V; Peyrefitte C; Thielens NM
    J Virol; 2016 Jun; 90(11):5256-5269. PubMed ID: 26984723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyphenylene carboxymethylene (PPCM) in vitro antiviral efficacy against Ebola virus in the context of a sexually transmitted infection.
    Escaffre O; Juelich TL; Freiberg AN
    Antiviral Res; 2019 Oct; 170():104567. PubMed ID: 31351092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection.
    Tan S; Lu L; Li L; Liu J; Oksov Y; Lu H; Jiang S; Liu S
    PLoS One; 2013; 8(3):e59777. PubMed ID: 23544097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils.
    Castellano LM; Hammond RM; Holmes VM; Weissman D; Shorter J
    Biol Open; 2015 Aug; 4(9):1206-12. PubMed ID: 26319581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.